Cited by 60Treatment of Major DepressionSleep and Wakefulness ResearchSleep and related disorders

The DOI matches its Crossref record.

Fluoxetine and Oculomotor Activity during Sleep in Depressed Patients

Armitage, R·1995·Neuropsychopharmacology

Abstract

The effects of fluoxetine on automated measures of electrooculographic (EOG) and electromyographic (EMG) activity were evaluated in 41 patients with nonpsychotic, major depressive disorder. Sleep EEG evaluations were conducted at baseline, while patients were symptomatic and unmedicated, and following four to five weeks of treatment with fluoxetine (20 mg). The number of eye movements (> 75 microV) and the amplitude of EOG and EMG activity increased significantly on treatment in REM, stages 1, 2, and slow-wave sleep. All patients showed EOG and EMG abnormalities in at least one stage of sleep. Thirty-four percent of patients showed increased EOG and EMG activity on treatment in every sleep stage. It is suggested that fluoxetine-induced oculomotor abnormalities are likely to be the result of increased availability of serotonin and secondary dopaminergic effects.

Overview

Integrity signals

Registry

Crossref · 10.1016/0893-133x(94)00075-b

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fluoxetine use is associated with an increased number of oculomotor movements during non-rapid eye movement (NREM) sleep.

    “An additional sleep physiology phenomenon has been reported with fluoxetine use; that of an increased number of oculomotor movements during non-rapid eye movement (NREM) sleep [Keck et al., 1991;Schenck et al., 1992;Armitage et al., 1995;Dorsey and Lukas, 1996].”

    From Depression, sleep physiology, and antidepressant drugs (2001) · cites this paper as Armitage et al., 1995

Citations

Cited by

Sorted by citations

Metadata

Authors
Armitage, R.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
Armitage, R
Venue
Neuropsychopharmacology
Published
1995-04
Volume
12
Issue
2
Pages
159-165
ISSN
0893-133X (ISSN-L)
OpenAlex
W2047622527
Cited by
60
References
0
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 2
FWCI
1.10
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (P50MH041115)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
fluoxetine, major depressive disorder, oculomotor behavior, eye movements, electrooculography, electromyography, sleep, REM sleep, slow-wave sleep, serotonin, dopaminergic effects, antidepressant side effects
MeSH terms
Adolescent, Adult, Aged, Ambulatory Care, Depression, Electroencephalography, Electromyography, Electrooculography, Eye Movements, Female, Fluoxetine, Humans, Male, Middle Aged, Sleep, Sleep Wake Disorders, Sleep, REM, Ocular Motility Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review